Premium Information is available for this item - Upgrade for $1 a day
6505-01-230-3133
Usp Tolazamide Tablets
6505012303133 012303133 NDC00009-0070-02 NDC00005-3067-23 TOLINASE TOLINASE TABLETS
INC: 31002 Tolazamide Tablets
January 2023
4
Marketplace 6505-01-230-3133
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-230-3133 5+ Documents (More...)
by United States NSN Created on by United States NSN Created on TOLINASE TABLETS NDC00009-0114-06 Managed
States NSN Created on 13 Jan 1972 Data Last Changed Usp Tolazamide Tablets 6505004024269TOLINASE TOLINASE
Usp Tolazamide Tablets 6505004024269TOLINASE TOLINASE TABLETS NDC00009-0114-06 Managed by United https
//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-230-3133 Usp Tolazamide Tablets 6505012303133 NDC00005
https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-230-3133 Usp Tolazamide Tablets 6505012303133 TOLINASE
https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-402-4269 Usp Tolazamide Tablets 6505004024269 TOLINASE
TOLINASE TABLETS NDC00009-0070-02 Managed by United States NSN Created on 13 Jan 1972 Data Last Changed
Usp Tolazamide Tablets 6505004024269TOLINASE TOLINASE TABLETS NDC00009-0114-06 Managed by United https
a day Upgrade your Account Upgrade 6505-00-402-4269Usp Tolazamide Tablets6505004024269 004024269 TOLINASE
TOLINASE TABLETS NDC00009-0070-02 Managed by United States NSN Created on 13 Jan 1972 Data Last Changed
Restrictions 6505-01-230-3133
6505-01-230-3133 is a Usp Tolazamide Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-230-3133
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-230-3133
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-230-3133
- Part Number
- Manufacturer
- Status
- NDC00009-0070-02
- Manufacturer
- 93703 - Pharmacia & Upjohn Company (Active)
- Incomplete Reference
- Incomplete Reference
- NDC00005-3067-23
- 2K656 - Lederle Laboratories Div Of American (Active)
- Incomplete Reference
- Incomplete Reference
- TOLINASE
- 93703 - Pharmacia & Upjohn Company (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
- TOLINASE TABLETS
- 93703 - Pharmacia & Upjohn Company (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-230-3133
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 100.000 Milligrams Tolazamide Active Ingredient
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
- Supplementary Features [SUPP]
- Lederle Medsep Item For Dod
Management Data 6505-01-230-3133
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Feb 1987
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 100 Tt
- 00000000100TT
- K
Similar Supply Items to 6505-01-230-3133
Freight Information 6505-01-230-3133
6505-01-230-3133 has freight characteristics managed by the Bonneville Power Administration.. 6505-01-230-3133 has a variance between NMFC and UFC when transported by rail and the description should be consulted.